Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 12:24 AM
NCT ID:
NCT01165658
Eligibility Criteria:
Inclusion Criteria:
1. Histologically or cytologically documented NSCLC, SCLC, thymic tumors, or carcinoid tumors
2. Patients not receiving concurrent chemotherapy
3. Patients that are eligible for concurrent treatment with biologic agents (epidermal growth factor receptor \[EGFR\] or vascular endothelial growth factor \[VEGF\] inhibitors) will be eligible for the study.
Exclusion Criteria:
1. Prior radiotherapy to the chest
2. Life expectancy \<6 months
3. Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01165658
Study Brief:
Protocol Section:
NCT01165658